Concert Pharmaceuticals, Inc. Earnings Per Share, Basic and Diluted
Concert Pharmaceuticals, Inc. reported Earnings Per Share, Basic and Diluted of -$0.67 per share for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-04.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2021-05-04
- Concert Pharmaceuticals, Inc. earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$0.67.
- Concert Pharmaceuticals, Inc. earnings per share, basic and diluted for the quarter ending 2020-12-31 was -$0.69.
- Concert Pharmaceuticals, Inc. earnings per share, basic and diluted for the quarter ending 2020-09-30 was -$0.60.
- Concert Pharmaceuticals, Inc. earnings per share, basic and diluted for the quarter ending 2020-06-30 was -$0.41.
- Concert Pharmaceuticals, Inc. earnings per share, basic and diluted for fiscal 2020 was -$2.40.
- Concert Pharmaceuticals, Inc. earnings per share, basic and diluted for fiscal 2019 was -$3.29.
- Concert Pharmaceuticals, Inc. earnings per share, basic and diluted for fiscal 2018 was -$2.40.
- Concert Pharmaceuticals, Inc. earnings per share, basic and diluted for fiscal 2014 was -$2.00.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2021-03-31 | -$0.67 10-Q · filed 2021-05-04 | |||
| 2020-12-31 | -$0.69 10-K · filed 2021-02-25 | -$2.40 10-K · filed 2021-02-25 | ||
| 2020-09-30 | -$0.60 10-K · filed 2021-02-25 | -$1.71 10-Q · filed 2020-11-05 | ||
| 2020-06-30 | -$0.41 10-K · filed 2021-02-25 | -$1.11 10-Q · filed 2020-08-06 | ||
| 2020-03-31 | -$0.70 10-Q · filed 2021-05-04 | |||
| 2019-12-31 | -$0.86 10-K · filed 2021-02-25 | -$3.29 10-K · filed 2021-02-25 | ||
| 2019-09-30 | -$0.72 10-K · filed 2021-02-25 | -$2.43 10-Q · filed 2020-11-05 | ||
| 2019-06-30 | -$0.78 10-K · filed 2021-02-25 | -$1.71 10-Q · filed 2020-08-06 | ||
| 2019-03-31 | -$0.93 10-K · filed 2021-02-25 | |||
| 2018-12-31 | -$0.89 10-K · filed 2020-02-27 | -$1.63 derived: net income ÷ weighted average shares · filed 2020-02-27 | -$2.20 derived: net income ÷ weighted average shares · filed 2020-02-27 | -$2.40 10-K · filed 2020-02-27 |
| 2018-09-30 | -$0.74 10-K · filed 2020-02-27 | -$1.31 derived: net income ÷ weighted average shares · filed 2019-11-07 | -$1.51 10-Q · filed 2019-11-07 | |
| 2018-06-30 | -$0.57 10-K · filed 2020-02-27 | -$0.76 10-Q · filed 2019-08-01 | ||
| 2018-03-31 | -$0.19 10-K · filed 2020-02-27 | |||
| 2017-06-30 | -$0.58 10-Q · filed 2018-08-02 | -$1.17 10-Q · filed 2018-08-02 | ||
| 2017-03-31 | -$0.60 10-Q · filed 2018-05-03 | |||
| 2016-12-31 | -$0.54 10-K · filed 2018-03-01 | |||
| 2016-09-30 | -$0.51 10-K · filed 2018-03-01 | |||
| 2016-06-30 | -$0.60 10-K · filed 2018-03-01 | -$1.23 10-Q · filed 2017-08-08 | ||
| 2016-03-31 | -$0.63 10-K · filed 2018-03-01 | |||
| 2015-03-31 | -$0.48 10-Q · filed 2016-05-05 | |||
| 2014-12-31 | -$0.49 10-K · filed 2016-03-01 | -$0.92 derived: net income ÷ weighted average shares · filed 2017-03-06 | -$2.00 10-K · filed 2015-03-02 | |
| 2014-09-30 | -$0.43 10-K · filed 2016-03-01 | -$1.52 10-Q · filed 2014-11-12 | ||
| 2014-06-30 | -$0.45 10-K · filed 2016-03-01 | -$1.11 10-Q · filed 2014-08-12 | ||
| 2014-03-31 | -$0.76 10-K · filed 2016-03-01 | -$2.48 derived: net income ÷ weighted average shares · filed 2016-03-01 | -$5.16 derived: net income ÷ weighted average shares · filed 2016-03-01 | |
| 2013-12-31 | -$4.64 10-K · filed 2015-03-02 | -$10.23 derived: net income ÷ weighted average shares · filed 2016-03-01 | -$4.99 10-K · filed 2015-03-02 | |
| 2013-09-30 | -$5.59 10-K · filed 2015-03-02 | -$0.34 10-Q · filed 2014-11-12 | ||
| 2013-06-30 | $0.00 10-K · filed 2015-03-02 | |||
| 2013-03-31 | -$1.46 10-K · filed 2015-03-02 | |||
| 2012-12-31 | -$16.15 10-K · filed 2015-03-02 |